FTL Gene

📖 Wiki Page

gene1271 wordssynced 2026-04-02

FTL Gene

<div class="infobox infobox-gene">
<table>
<tr><th colspan="2" style="background:#1976D2; color:white;">FTL</th></tr>
<tr><td><strong>Full Name</strong></td><td>Ferritin Light Chain</td></tr>
<tr><td><strong>Gene Symbol</strong></td><td>FTL</td></tr>
<tr><td><strong>Chromosomal Location</strong></td><td>19q13.33</td></tr>
<tr><td><strong>NCBI Gene ID</strong></td><td>2512</td></tr>
<tr><td><strong>OMIM ID</strong></td><td>134790</td></tr>
<tr><td><strong>Ensembl ID</strong></td><td>ENSG00000196954</td></tr>
<tr><td><strong>UniProt ID</strong></td><td>P02792</td></tr>
<tr><td><strong>Protein Family</strong></td><td>Ferritin light chain subunit</td></tr>
<tr><td><strong>Associated Diseases</strong></td><td>Neuroferritinopathy, Alzheimer's Disease, Parkinson's Disease, NBIA</td></tr>
</table>
</div>

Introduction

FTL encodes the ferritin light chain (FTL) subunit, a critical component of the ferritin protein complex that serves as the primary intracellular iron storage system in eukaryotes. Ferritin is a 24-subunit protein shell (composed of heavy and light chains) capable of storing up to 4,500 iron atoms in a soluble, non-toxic form. The light chain possesses ferroxidase activity that converts toxic Fe²⁺ (ferrous iron) to Fe³⁺ (ferric iron) for safe storage within the protein cavity[@levi2005].

...

FTL Gene

Introduction

Dominant mutations in FTL cause neuroferritinopathy (also called ferritinopathy), a rare form of neurodegeneration with brain iron accumulation (NBIA) characterized by progressive movement disorders and iron deposition in the basal ganglia, cerebellum, and cerebral cortex[@mancuso2020]. Beyond this monogenic disorder, FTL and ferritin function are increasingly recognized as important factors in more common neurodegenerative diseases including Alzheimer's disease (AD), Parkinson's disease (PD), and amyotrophic lateral sclerosis (ALS)[@ward2014].

This comprehensive overview addresses the structure, function, and disease associations of FTL, with particular emphasis on its role in neurodegeneration and therapeutic implications.

Gene Structure and Function

Genomic Organization

The FTL gene is located on chromosome 19q13.33 and encodes the light chain subunit of ferritin. The gene structure has been conserved throughout evolution, reflecting its fundamental role in cellular iron homeostasis.

Key genomic features:

Chromosomal location: 19q13.33
Exon count: 4 exons
Promoter: Contains iron-responsive elements (IREs) for translational regulation
Alternative splicing: Produces tissue-specific isoforms

Protein Structure

FTL combines with the heavy chain (FTH1) to form the functional ferritin complex:

Mermaid diagram (expand to render)

Structural features:

Heteropolymer formation: 12 FTL + 12 FTH1 subunits (optimal ratio)
Hollow shell: 12-nm diameter cavity for iron storage
Ferroxidase center: Catalytic site for iron oxidation (primarily in heavy chain)
Iron nucleation sites: Light chain facilitates iron core formation
Shell stability: Provides structural integrity for the iron core

Molecular Function

Iron Storage and Homeostasis

FTL plays a central role in cellular iron homeostasis:

Iron sequestration:

Stores up to 4,500 iron atoms per ferritin molecule
Converts toxic Fe²⁺ to safe Fe³⁺ through ferroxidase activity
Prevents Fenton reaction-mediated oxidative damage

Cellular protection:

Antioxidant defense by sequestering free iron
Iron availability regulation during stress
Ferroptosis prevention through iron homeostasis

Ferritinophagy

The autophagic degradation of ferritin, termed ferritinophagy, is a critical process for iron recycling[@wang2014][@khan2019]:

NCOA4-mediated ferritinophagy:

NCOA4 (Nuclear Receptor Coactivator 4) delivers ferritin to lysosomes
Iron released during degradation supports cellular needs
Dysregulated ferritinophagy contributes to iron dysregulation in disease

Regulation:

Iron availability modulates ferritin degradation
mTORC1 inhibits ferritinophagy under high iron conditions
Autophagy regulation affects ferritin turnover

Role in Neurodegenerative Diseases

Neuroferritinopathy (Ferritinopathy)

Neuroferritinopathy is an autosomal dominant disorder caused by FTL mutations, particularly the 460dupA mutation[@curtis2001][@keogh2021]:

Clinical features:

Movement disorders: Chorea, dystonia, parkinsonism, tremor
Cognitive decline: Progressive dementia
Behavioral changes: Personality changes, depression
Onset: Typically adult-onset (third to sixth decade)

Neuroimaging findings:

Iron deposition in basal ganglia on MRI
Cerebellar and cortical iron accumulation
"Eye of the tiger" sign similar to other NBIA disorders

Pathogenic mechanisms[@barbaro2023]:

Loss of ferroxidase activity: Mutant FTL has reduced iron oxidation capacity

Iron release: Abnormal ferritin releases iron, causing oxidative damage

Aggregate formation: Mutant ferritin forms intracellular inclusions (ferritin immunopositive)

Cellular dysfunction: Neuronal death in iron-rich brain regions

Alzheimer's Disease

FTL and ferritin are implicated in AD pathogenesis through multiple mechanisms[@chen2020][@yang2021]:

Amyloid-ferritin relationship:

Ferritin found in amyloid plaques
Iron accumulation in AD brain regions
Ferritin may modulate amyloid-beta toxicity

Iron dysregulation:

Elevated ferritin in cerebrospinal fluid
Altered iron homeostasis in hippocampus
Contributes to oxidative stress

Therapeutic implications:

Iron chelation approaches being investigated
Modulating ferritin expression as potential therapy

Parkinson's Disease

FTL plays important roles in PD pathogenesis[@moore2019][@angelova2019]:

Dopaminergic neuron vulnerability:

High iron in substantia nigra
Ferritin expression changes in PD brains
Iron-induced oxidative stress in dopaminergic neurons

Alpha-synuclein interaction:

Ferritin may bind alpha-synuclein
Iron promotes alpha-synuclein aggregation
Ferritin dysfunction may contribute toLewy body formation

Therapeutic potential:

Iron chelation shows promise in PD models
Ferritin modulators under investigation

Amyotrophic Lateral SALS

Iron accumulation is observed in ALS, with FTL potentially involved[@chio2019]:

Elevated iron in motor cortex
Ferritin changes in ALS models
Iron dysregulation may contribute to motor neuron degeneration

Expression Pattern

Brain Region Distribution

FTL is widely expressed in the brain, with highest levels in iron-rich regions[@ward2014]:

| Brain Region | Expression Level | Cell Types |
|--------------|------------------|------------|
| Basal ganglia | Very high | Neurons, glia |
| Substantia nigra | Very high | Dopaminergic neurons |
| Cerebellum | High | Purkinje cells, dentate nucleus |
| Cerebral cortex | Moderate | Pyramidal neurons |
| Hippocampus | Moderate | CA neurons, dentate gyrus |
| Thalamus | Moderate | Various nuclei |

Cellular Localization

Neuronal expression:

Cytoplasmic distribution
Colocalization with mitochondria in some cell types
Axonal and dendritic presence

Glial expression:

Oligodendrocytes: High (myelin production requires iron)
Microglia: Moderate (iron recycling)
Astrocytes: Moderate (iron metabolism)

Therapeutic Implications

Current Treatment Strategies

Management of neuroferritinopathy and related disorders includes[@sawicka2024]:

Iron chelation therapy:
| Drug | Mechanism | Status |
|------|-----------|--------|
| Deferoxamine | Iron chelation | Clinical use |
| Deferasirox | Oral iron chelation | Clinical use |
| Deferiprone | Brain-penetrant | Research |

Antioxidant approaches:

Coenzyme Q10
Vitamin E
N-acetylcysteine

Gene therapy:

AAV-mediated wild-type FTL delivery
CRISPR-based gene correction
RNA interference for mutant alleles

Emerging Therapies

Ferritin modulation:

Small molecules targeting ferritin expression
Peptide-based inhibitors of aggregation
NCOA4 modulators for ferritinophagy

Iron homeostasis normalization:

Dietary iron modulation
Hepcidin modulators
Ferroportin targeted approaches

Animal Models

Genetic Models

Transgenic models:

FTL mutant transgenic mice: Recapitulate iron accumulation
Knockout models: Embryonic lethal (essential gene)
Conditional knockouts: Brain-specific phenotypes

Phenotypic observations:

Iron deposition in basal ganglia
Motor coordination deficits
Learning and memory impairment

Disease Models

Neuroferritinopathy models:

460dupA knock-in mice
Viral vector-mediated mutant expression

AD/PD models:

Ferritin expression changes in APP/α-syn models
Iron dysregulation studies

Summary

FTL encodes ferritin light chain, a fundamental component of the ferritin protein complex essential for iron storage and cellular protection against oxidative damage. Mutations in FTL cause neuroferritinopathy, a progressive neurodegenerative disorder characterized by movement disorders, cognitive decline, and iron accumulation in the brain.

Beyond monogenic disease, FTL and ferritin function are increasingly recognized as important factors in common neurodegenerative diseases including Alzheimer's disease, Parkinson's disease, and ALS. Iron dysregulation, altered ferritin expression, and impaired ferritinophagy all contribute to disease pathogenesis.

Therapeutic strategies targeting FTL and iron homeostasis include iron chelation, antioxidant therapy, and emerging gene therapy approaches. Understanding FTL function in neurodegeneration continues to inform therapeutic development for these devastating disorders.

External Links

[NCBI Gene: FTL](https://www.ncbi.nlm.nih.gov/gene/2512)
[UniProt: FTL](https://www.uniprot.org/uniprot/P02792)
[Ensembl: FTL](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000196954)
[OMIM: FTL](https://omim.org/entry/134790)
[NBIA Disorders Association](https://nbiadisorders.org/)
[GeneReviews: FTL-Related Neurodegeneration](https://www.ncbi.nlm.nih.gov/books/NBK1116/)

Pathway Diagram

The following diagram shows the key molecular relationships involving FTL Gene discovered through SciDEX knowledge graph analysis:

Mermaid diagram (expand to render)

📖 View canonical wiki page →

FTL Gene

FTL Gene

Introduction

FTL Gene

Introduction

Gene Structure and Function

Genomic Organization

Protein Structure

Molecular Function

Iron Storage and Homeostasis

Ferritinophagy

Role in Neurodegenerative Diseases

Neuroferritinopathy (Ferritinopathy)

Alzheimer's Disease

Parkinson's Disease

Amyotrophic Lateral SALS

Expression Pattern

Brain Region Distribution

Cellular Localization

Therapeutic Implications

Current Treatment Strategies

Emerging Therapies

Animal Models

Genetic Models

Disease Models

Summary

See Also

External Links

Pathway Diagram